SNTI Senti Biosciences Holdings, Inc.
Senti Biosciences Holdings, Inc. (SNTI) is expected to report earnings on November 13, 2026, after the market close. The consensus earnings estimate is a loss of $0.38 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +12.3% since its last earnings release on August 14, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Senti Biosciences Holdings, Inc.
Senti Biosciences Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary gene circuit platform. Senti Biosciences Inc., formerly known as Dynamics Special Purpose Corp., is based in SOUTH SAN FRANCISCO, Calif.
Sector
Healthcare
Industry
Biotechnology